Xylem Stock Falls As FY22 Outlook Lags Consensus

  • Xylem Inc XYL reported a fourth-quarter FY21 revenue decline of 3.6% year-over-year to $1.32 billion, beating the consensus of $1.31 billion.
  • Sales by segments: Water Infrastructure $622 million (+1% Y/Y), Applied Water $406 million (+2.8% Y/Y), and Measurement & Control Solutions $295 million (-18.5% Y/Y).
  • Adjusted EPS was $0.63, beating the consensus of $0.61.
  • Adjusted operating income declined 22.2% Y/Y to $147 million, and margin contracted by 265 bps to 11.1%.
  • The company generated $538 million of operating cash flow, representing a 126% conversion, and $330 million of free cash flow, representing a 77% conversion for the fiscal.
  • Adjusted EBITDA was $214 million, compared to $258 million in 4Q20, and the margin was down 260 bps to 16.2%.
  • Dividend: Xylem board declared a dividend of $0.30 per share, an increase of 7%, payable on March 17, 2022, to shareholders of record as of February 17, 2022.
  • "We expect the first half of 2022 to continue to be supply-constrained due to ongoing chip shortages," said CEO Patrick Decker.
  • "Overall, we expect full-year growth in the mid-single digits, with significant margin expansion in the second half, keeping us on track to achieve our 2025 growth and strategic milestones," Decker added.
  • FY22 Outlook: Xylem expects revenue of $5.25 billion - $5.35 billion (consensus $5.49 billion), up 1% - 3% on a reported basis and up 3% - 5% on an organic basis.
  • It expects an adjusted EPS of $2.35 - $2.70 (vs. consensus of $2.97), representing a decline of 6% to an increase of 8% year-over-year.
  • Price Action: XYL shares traded lower by 7.90% at $95.95 on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceDividendsMoversTrading IdeasBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!